Clinical Trial Update: Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma: [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated liposomal irinotecan in combination with oxaliplatin, leucovorin, and 5-fluorouracil in locally advanced pancreatic cancer. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Adrucil (5-fluorouracil)
• Eloxatin (oxaliplatin)
• Onivyde (irinotecan hydrochloride liposome injection)
• Wellcovorin (leucovorin calcium)

Snippet

Sponsor: Nelson Yee | Conditions: Locally Advanced Pancreatic Carcinoma(LAPC) | Phase 2 | Status: COMPLETED | Results posted: 2025-04-18